Logo

Pharmoptima, Shamrock Form Joint Services Alliance

Oct 20, 2004

NEW YORK, Oct. 20 (GenomeWeb News) - PharmOptima and Shamrock Structures jointly announced today that they will offer each other's capabilities and services for drug discovery and research applications.

 

Woodbridge, Ill.-based Shamrock provides customers with proteomics services and access to X-ray synchrotron data collection. PharmOptima optimizes assays for high-throughput screening and is conducting research on its own portfolio of therapeutic products.

 

Terms of the agreement were not disclosed.

Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.